← Open Payments lookup

SAMANTHA GAUVIN: Open Payments

NPI 1144902636 · CEDAR BLUFF, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,348 in 66 payments from 8 companies in 2025. Trend: 2023 $76 · 2024 $1,331 · 2025 $1,348

Food & beverage: $1,272Education: $76
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$288
E.R. Squibb & Sons, L.L.C.10$273
Teva Pharmaceuticals USA, Inc.15$260
ABBVIE INC.14$145
Janssen Pharmaceuticals, Inc7$144
Otsuka America Pharmaceutical, Inc.2$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Alkermes, Inc.2$31

Products named: INGREZZA, COBENFY, AUSTEDO XR, VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA, ARISTADA.

Industry payments across VA — which companies pay providers there.